The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Markets recently faced volatility driven by Fed cuts, resilient economic data, and persistent inflation concerns, leading to subdued sentiment. Click to read.

Take a look at our top picks, then let us walk you through making the decision. Many or all of the products on this page are from partners who compensate us when you click to or take an action on ...